As part of its Evidence Gap series, the New York Times has a backgrounder on the obstacles facing personalized medicine -- getting pharmaceutical companies to develop tests, insurance companies to cover the cost, and doctors to order the test. It also goes into the confusion of contradictory validation study results as well as from inconclusive test results, saying it is not always clear what should be done medically.